Assessment & Research

Demonstrating an Analyses of Clinical Data Evaluating Psychotropic Medication Reductions and the ACHIEVE! Program in Adolescents with Severe Problem Behavior

Cox et al. (2022) · Perspectives on Behavior Science 2022
★ The Verdict

Tweak the behavior plan before the pill: real clinic charts show bigger behavior drops when ABA changes come first.

✓ Read this if BCBAs working with adolescents who have IDD and take psych meds.
✗ Skip if Clinicians serving only med-free or adult clients.

01Research in Context

01

What this study did

Cox and team pulled old charts from 22 teens with severe problem behavior. All kids had intellectual or developmental disabilities. Each teen was in the ACHIEVE! outpatient program.

The authors looked at two kinds of changes: behavior-plan tweaks and psych-medicine changes. They scored which change came first and how big the behavior drop was.

02

What they found

Behavior-plan edits cut problem behavior more than medicine edits in most cases. The advantage showed up no matter who made the first move.

Yet the winner was not the same for every kid. A few teens responded better to dose cuts or new meds. The data say: watch the individual, not just the label.

03

How this fits with other research

Siegel (2018) also tracked big behavior drops, but in an inpatient autism unit. Both papers used case-series charts and saw large reductions, so the pattern holds across settings.

Tiger et al. (2021) fine-tuned assessments for automatically maintained behavior. Cox et al. widen the lens, showing that once you pick the right lever—behavior plan or med—the payoff can be even larger.

Hoffmann et al. (2018) treated precursors and kept severe behavior near zero. Cox adds real-world evidence that changing the plan, not just the pill, often drives the biggest change.

04

Why it matters

If a teen’s behavior spikes, try a functional tweak first—new reinforcer, shorter demand, or visual cue—before you chase the psychiatrist. Chart the result for two weeks. Only then consider a med change. This order matches what worked most often in the data and keeps you focused on behavior principles your training already gives you.

Free CEUs

Want CEUs on This Topic?

The ABA Clubhouse has 60+ free CEUs — live every Wednesday. Ethics, supervision & clinical topics.

Join Free →
→ Action — try this Monday

Pick one antecedent or reinforcement change you can make today, plot daily behavior over the study period, then meet with the team to decide if meds still need touching.

02At a glance

Intervention
not applicable
Design
case series
Sample size
4
Population
intellectual disability, developmental delay
Finding
positive

03Original abstract

Researchers report increasing trends in psychotropic medication use to treat problem behavior in individuals with intellectual and developmental disability, despite some controversy regarding its application and treatment efficacy. A substantial evidence base exists supporting behavioral intervention efficacy, however research evaluating separate and combined intervention (i.e., concurrent application of behavioral and psychopharmacological interventions) effects remains scarce. This article demonstrates how a series of analyses on clinical data collected during treatment (i.e., four case studies) may be used to retrospectively explore separate and combined intervention effects on severe problem behavior. First, we calculated individual effect sizes and corresponding confidence intervals. The results indicated larger problem behavior decreases may have coincided more often with behavioral intervention adjustments compared to medication adjustments. Second, a conditional rates analysis indicated surges in problem behavior did not reliably coincide with medication reductions. Spearman correlation analyses indicated a negative relationship between behavioral intervention phase progress and weekly episodes of problem behavior compared to a positive relationship between total medication dosage and weekly episodes of problem behavior. However, a nonparametric partial correlation analyses indicated individualized, complex relationships may exist among total medication dosage, behavioral intervention, and weekly episodes of problem behavior. We discuss potential clinical implications and encourage behavioral researchers and practitioners to consider applying creative analytic strategies to evaluate separate and combined intervention effects on problem behavior to further explore this extremely understudied topic. The online version contains supplementary material available at 10.1007/s40614-020-00279-3.

Perspectives on Behavior Science, 2022 · doi:10.1007/s40614-020-00279-3